CoChat

Enteroviral Meningitis: Natural History and Outcome of Pleconaril Therapy

Desmond, R. A., Accortt, N. A., Talley, L., Villano, S. A., Soong, S.-J., Whitley, R. J. · 2006 · Antimicrobial Agents and Chemotherapy

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Enteroviral meningitis causes appreciable morbidity in adults, including hospitalization, decreased activity, and headache. Limited data define the natural history of disease. No antiviral therapeutic agent has demonstrated improved outcome in controlled clinical trials. Pleconaril, an inhibitor of enterovirus replication, was tested in two placebo-controlled clinical trials. Of 607 randomized patients in a multicenter, double-blind placebo-controlled study of pleconaril (200 mg three times daily versus an identical-appearing placebo), 240 patients were confirmed to have enterovirus infection. The time to headache resolution was evaluated by using Kaplan-Meier survival methodology. A Cox regression model evaluated multivariate factors associated with disease resolution. Resolution of headache in patients with concomitant moderate to severe nausea at baseline occurred at a median of 9.5 days in the absence of therapy and was reduced to 7.0 days for pleconaril recipients ( P = 0.009). For a headache score of >5 alone, treated patients resolved headache significantly more rapidly ( P = 0.005). Males resolved headache 50% faster than females. Regardless of randomization group, patients with a baseline headache score of 5 or greater resolved headache 50% more slowly than patients with a baseline headache score of 4. No differences in either clinical or laboratory adverse events were noted. Over 50% of untreated patients had a persistent headache that was greater than 1 week in duration. Pleconaril shortened the course of illness compared to placebo recipients, especially in the early disease course. However, the benefit was achieved only modestly in a subgroup analysis of patients with more severe disease after adjusting for confounding variables.

Overview

Integrity signals

Registry

Crossref · 10.1128/aac.00227-06

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 11 references

Cited by

See all 154

Metadata

Authors
Desmond, R. A., Accortt, N. A., Talley, L., Villano, S. A., Soong, S.-J., & Whitley, R. J.
Affiliations
  • University of Alabama at Birmingham (US)
  • Emmes (United States) (US)
  • ViroPharma Incorporated, Exton, Pennsylvania
Corresponding author
Whitley, R. J.
Venue
Antimicrobial Agents and Chemotherapy
Published
2006-07
Volume
50
Issue
7
Pages
2409-2414
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W2016502913
Cited by
154
References
11
Citations by year
2026: 3 · 2025: 2 · 2024: 6 · 2023: 4 · 2022: 7 · 2021: 7 · 2020: 5 · 2019: 5 · 2018: 7 · 2017: 5 · 2016: 10 · 2015: 13 · 2014: 10 · 2013: 12 · 2012: 10
FWCI
6.16
Type
journal article
Language
en
Open access
closed
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Antimicrobial Agents and Chemotherapy (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (n01ai30025-8-0-2, n01ai065306-000, n01ai062554-008, n01ai015113-000)
  • National Institute of Allergy and Infectious Diseases (N01-AI -15113, N01 AI 62554, N01 AI030025, N01‐AI‐65306)
  • National Center for Research Resources (RR-032)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
  • Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
  • Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
Keywords
enteroviral meningitis, pleconaril, headache resolution, natural history of disease, antiviral therapy, nausea, sex differences in recovery, persistent headache
MeSH terms
Adult, Antiviral Agents, Double-Blind Method, Enterovirus Infections, Female, Headache, Humans, Male, Meningitis, Viral, Oxadiazoles, Oxazoles, Multivariate Analysis, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Enteroviral Meningitis: Natural History and Outcome of Pleconaril Therapy. https://app.cochat.ai/papers/10.1128/aac.00227-06
The paper
Desmond, R. A., Accortt, N. A., Talley, L., Villano, S. A., Soong, S.-J., & Whitley, R. J. (2006). Enteroviral Meningitis: Natural History and Outcome of Pleconaril Therapy. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00227-06

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.